CN105193995A - Quick-acting traditional Chinese medicine granules for treating heart diseases - Google Patents
Quick-acting traditional Chinese medicine granules for treating heart diseases Download PDFInfo
- Publication number
- CN105193995A CN105193995A CN201510725963.2A CN201510725963A CN105193995A CN 105193995 A CN105193995 A CN 105193995A CN 201510725963 A CN201510725963 A CN 201510725963A CN 105193995 A CN105193995 A CN 105193995A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- heart
- traditional chinese
- medicine granules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses quick-acting traditional Chinese medicine granules for treating heart diseases. The quick-acting traditional Chinese medicine granules are technically characterized by comprising 3-9 parts of pseudo ginseng, 2-6 parts of roses and 2-4 parts of white sugar. The traditional Chinese medicine granules have the efficacy of promotion of qi circulation, pain relief, promotion of blood circulation and stasis removal and can effectively increase coronary blood flow, remove blood stasis and relieve and treat angina pectoris and a coronary heart disease.
Description
Technical field
The invention belongs to tcm field, relate to Chinese medicinal composition preparation and using method thereof that a kind of fast-acting treatment heart disease sends out.
Background technology
Coronary heart disease and angina pectoris are frequently-occurring disease, the regular incidence of middle-aged and elderly people.Anginal direct pathogenic factor is deficiency myocardial blood supply.And deficiency myocardial blood supply mainly comes from coronary heart disease.If fat constantly deposition, will form speckle in blood vessel.If speckle occurs in coronary artery, its constriction will be caused, reduce it further to the blood supply of cardiac muscle, just define coronary heart disease.The process that in coronary artery, the continuous deposition of fat forms speckle is gradually called coronary atherosclerosis.The accumulation of this speckle of coronary artery inwall can cause angina pectoris in following two kinds of modes: 1. fixed position coronarius tube chamber constriction, so cause through blood flow greatly reduce; 2. the some or all of blocked coronary arteries of the blood clotting formed.Angina pectoris just needs emergency treatment once outbreak, otherwise very easily brings out acute myocardial infarction, and treatment common drug is all kinds ofly rescue heart preparation.
Fast-acting heart disease curing commonly uses western medicine medicine nitroglycerin, nitroglycerin is rapid-action, the effect of coronary dilating arteries and veins is strong, but nitroglycerin is fugitive preparation, the rapid-action persistent period, short (3-5 minute) can only use when angina pectoris attacks, cannot Sustainable Control angina pectoris, even if there is the nitrate esters preparation of long action time, mitigate the disease effect is played in basic role exactly, cannot treat angina pectoris and coronary heart disease.Beta-blockers (Beta receptor blockers) has and blocks the sympathomimetic amine stimulation to heart rate and contractile force receptor, and decreased heart rate, reduces blood pressure, and lowers myocardial contraction and oxygen consumption, thus the outbreak of allevating angina pectoris, cure the symptoms, not the disease.Of the same type also has calcium channel blocker and coronary artery dilator class medicine, is substantially all relief of symptoms, effectively can not solve the basic reason that disease is sent out.
The Chinese medicine SUXIAO JIUXIN WAN of current listing forms, for qi stagnation and blood stasis type coronary heart diseases and angina pectoris primarily of Rhizoma Chuanxiong and Borneolum Syntheticum.But the key issues such as this adverse effect, taboo, points for attention are still not clear, and bring certain risk to medication, in particular for the treatment of acute angina pectoris and coronary heart attack, very risky.And should not take for the patients such as hypertensive headache, cerebral tumor headache, liver-fire headache and hyperactivity of fire caused by deficiency of YIN person, mainly effect of Rhizoma Chuanxiong should not be used for the treatment of the above-mentioned type patient.
In view of above-mentioned bottleneck, find a kind of application type more extensive, the drug effect fast-acting heart disease curing medicine that the time is long quickly and consistently, really can treat disease, reach " rescuing the heart " effect, have urgent realistic meaning.
Summary of the invention
Medical research confirms, the basic reason of coronary heart diseases and angina pectoris class heart disease disease is that congestion that a variety of causes causes, atherosclerosis, lipidosis, blood vessel are narrow, thus causes blood supply insufficiency.Therefore the root problem solved just is to get through to silt up, middle medical drugs should from circulation of qi promoting, pain relieving, invigorate blood circulation, blood stasis dispelling starts with.
The object of the invention is to overcome the deficiencies in the prior art, provide a kind of Chinese medicine composition to rescue heart preparation, there is effect of promoting the circulation of QI to relieve pain, blood circulation promoting and blood stasis dispelling, increase coronary flow, remove blood stasis, alleviate and treat angina pectoris and coronary heart disease.
Chinese medicine composition of the present invention rescues heart preparation, and its composition is made up of Radix Notoginseng, Flos Rosae Rugosae, white sugar.
Chinese medicine composition of the present invention rescues heart preparation, its use time each Ingredients Weight proportioning be Radix Notoginseng 3 ~ 9 parts, Flos Rosae Rugosae 2 ~ 6 parts, white sugar 2 ~ 4 parts composition.
It is as follows that Chinese medicine composition of the present invention rescues heart preparation component base used pharmacological effect: Radix Notoginseng, dissipating blood stasis, hemostasis, detumescence, analgesic therapy; Flos Rosae Rugosae, brownish red, with just as the heart, gas thick flavor, circulation of qi promoting, resolving depression and blood, pain relieving; White sugar, the lung moistening and production of body fluid promoting, invigorating the spleen and replenishing QI, heat clearing and damp drying, preventing phlegm from forming and stopping coughing, the turbid descending are soothed the spirit, fast invigorating middle warmer gas.
Radix Notoginseng has another name called Radix Notoginseng, and the famous pharmacy man Li Shizhen (1518-1593 A.D.) of the Ming Dynasty is called " Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) ".Radix Notoginseng is a jewel in Chinese crude drug, and record in Qing Dynasty's pharmaceutical texts supplementary Amplifications of the Compendium of Materia Medica: ginseng qi-tonifying the first, Radix Notoginseng enriches blood the first, taste with and merit also etc., therefore claiming Panax pseudoginseng, is the most precious person in Chinese medicine.Becoming famous the Chinese patent medicine " YUNNAN BAIYAO " of China and foreign countries and " sheet young Huang ", is namely that primary raw material is made with Radix Notoginseng.Radix Notoginseng dissipating blood stasis stops blooding, the pharmacological action that subduing swelling and relieving pain effect is relevant is very extensive, comprise hemostasis, antithrombotic, promotion hemopoietic, expand blood vessel, blood pressure lowering, resist myocardial ischemia, anti-cerebral ischemia, arrhythmia, atherosclerosis, antiinflammatory, protect the liver, antitumor, the effect such as analgesia, principle active component is PNS, PDS, PTS and Radix Notoginseng propylhomoserin.
Chinese medicine composition of the present invention rescues heart preparation, and form of medication is electuary, takes 5-10 minute energy rapid-onset, wins the best quality time, successful rescue effect more than 90% to rescue.
Chinese medicine composition of the present invention, uses medicinal herbs most in use, and without expensive, rare medical material, therefore low cost, electuary administration in addition, has followed Chinese medicine tradition, had and use preferably and treat operability.
Chinese medicine composition of the present invention, according to galenic pharmacy principle, can be developed to the medicine of different way of administration and dosage form, oral tablet, capsule, pill, powder, oral liquid.
Leading reference: [1] Zhou Chunyou. Radix Notoginseng powder treatment angina pectoris 43 example [J]. Jiangxi Chinese medicine, 2002,33 (1): 10; [2] Wu Yuling, Li Ying, Bai Xue. the FUFANG SANQI JIAONANG treatment routine clinical observation of angina pectoris 60 [J]. Chinese Medicine Leader, 2009,6 (11): 74; [3] Guo Lei, Shi Lei. the progress [J] of Radix Notoginseng total arasaponins treatment angina pectoris. modern combination of Chinese and Western medicine magazine, 2010,19 (10): 1290; [4] Meng Aijun. the pharmacological action [J] of Flos Rosae Rugosae. community medicine magazine, 2009,7 (2): 71; [6] Wang Duoning. the comprehensive utilization of Flos Rosae Rugosae and DEVELOPMENT PROSPECT [J]. Exploitation of Agriculture in Heilongjiang science, 2010,1:117.
Clinical efficacy
1. clinical information
Sample information is that in JIUYUE, 2009 to 2015 meets subject typical clinical patient year March, samples selection meets 1979 " name of ischemic heart desease and diagnostic criteria " that WHO formulates, and Chinese medical discrimination adopts " guideline of clinical investigations of the new Chinese medicine treatment thoracic obstruction (angina pectoris) " of Ministry of Public Health formulation in 1993.Man 22 example in patient, female 19 example, 42 to 75 years old ages.The course of disease 5 months to 12 years is not etc.Patient is many through western medicine unsatisfactory curative effect, uses Chinese medicine impact treatment of the present invention instead.
2. Therapeutic Method: use Chinese medicine composition of the present invention to rescue heart electuary, rescues genuinely convinced use, each potion, every agent 10 grams when sick; Treatment uses every day two doses, every agent 5 grams, sooner or later each potion, and one after each meal, taking continuously 15th is a course for the treatment of.
3. therapeutic outcome:
Send out for heart disease and rescue heart preparation, 37 routine rapid-onset, relief of symptoms, is effective, invalid 4 examples.Success rate 90%.Send out treatment rear for heart disease, 35 examples are cured, and 3 examples are improved, and 3 examples are invalid.Total effective rate 85%.Wherein cure in 4 courses for the treatment of and reach 25 examples; 4-6 the course for the treatment of cures patient 8 example; 2 routine patients are extended patient, finally cure through more than 10 courses for the treatment of; 3 routine patients cause heart disease to be difficult to cure because of diabetes and hyperlipidemia, improve the state of an illness.3 examples are invalid.
4. model case
(1) Liu, man, 51 years old.Patient in June, 2012 here see a doctor, main suit walks up and starts to occur precordialgia, in vexed pain, hurriedly can not breathe, otherwise be difficult to stand.Ache with upper limb, each lasting tens seconds to 1 minute, rest a few minutes can be alleviated, and monthly show effect 1-2 time after that.On April 7th, 2013, burst was uncomfortable in chest, and angor is fallen faintness, a few minutes complexion blue, household promptly ask I go treatment, because pathology is unclear, only carry rescue heart electuary go cure, after showing up, patient has taken nitroglycerin and has rescued the heart, alleviate, still can not severe breathe, myasthenia of limbs, through inquiry, learn that patient has essential hypertension history, with moderate angina pectoris, take Western medicine pills for curing heart disease and also the degree of depth cannot improve the state of an illness.For this situation, I debates in conjunction with the traditional Chinese medical science scheme of controlling, and according to patient for disease qi stagnation hemagglutination disease treatment requirement, takes the Therapeutic Method of " benefiting QI for activating blood circulation, disperse blood stasis and dredge collateral ".Suggestion patient uses electuary agent of the present invention to be absorbed in treatment, is aided with ban on opium-smoking and the opium trade wine, appropriate exercise simultaneously.Drug therapy medicine improves rapidly breathing and ability to act.After 2 courses for the treatment of, breathe, uncomfortable in chest, chest pain significantly alleviates, occasionally have hardwork to feel slightly to compensate.After 4 courses for the treatment of, chest pain symptom also disappears completely.Hospital has an electro-cardiogram and lab testing, and display is normal.
(2) king so-and-so, man, 45 years old.On April 17th, 2013, heart attack is fainted, and its household runs quickly to seek medical advice, and uses the present invention to rescue heart electuary and revives for 5 minutes, go examination in hospital to treat after Consciousness.Through looking into, patient ECG is sinus rhythm, and V5, V6ST section level of approximation moves down 0.05-0.75mV, and T ripple is low flat.Routine blood test indices is normal.Ultrasoundcardiogram display Left Ventricular, left atrium are bigger, and interventricular septum middle and lower part and in the heart portion's motion amplitude reduce, and move inharmonious with left ventricular posterior wall.Prompting regional myocardial ischemia is strong anginal evidence.Hospitalization 2 months, disease amelioration, recuperation of going home.On August 2nd, 2013, sick recurrence, promptly takes nitroglycerin and rescues the non-onset of the heart, add after the present invention rescues heart electuary and revive, be admitted to hospital into serious symptom therapeutic room 3 days, out of danger, but extremity have that obviously to send out cool stiff, after leave hospital to come here and seek medical advice, accept my suggestion, use treatment by Chinese herbs, stop research, after 6 months, recover completely, visit so far, do not recur.
Detailed description of the invention
Be described principle of the present invention and feature below in conjunction with concrete embodiment, example, only for explaining the present invention, does not limit content of the present invention.All in the spirit and principles in the present invention, any amendment, replacement, improvement etc. done, all should be included within protection scope of the present invention.
Embodiment one
Prescription: Radix Notoginseng 90 grams, Flos Rosae Rugosae 60 grams, white sugar 40 grams.
Powder: get Radix Notoginseng, Flos Rosae Rugosae, cleaning, drying, fine ground powder.Add white sugar mixing, pack, 10 grams every bag is potion.
This compositions proportioning, preferentially for the treatment of acute cardiac seizure of disease, plays and rescues rapidly heart effect.
Embodiment two
Prescription is prepared: Radix Notoginseng 30 grams, Flos Rosae Rugosae 30 grams, white sugar 20 grams.
Powder: get Radix Notoginseng, Flos Rosae Rugosae, cleaning, drying, fine ground powder.Add white sugar mixing, pack, 5 grams every bag is potion.
This compositions proportioning, long-term taking, for the treatment of the diseases such as coronary heart diseases and angina pectoris.Every day twice, sooner or later respectively once, one after each meal.
Claims (4)
1. a Chinese medicine fast-acting heart disease curing electuary, said composition is made up of following compositions: Radix Notoginseng, Flos Rosae Rugosae, white sugar.
2. Chinese medicine fast-acting heart disease curing electuary as claimed in claim 1, its each Parts by Ingredients proportioning is: Radix Notoginseng 3 ~ 9 parts, Flos Rosae Rugosae 2 ~ 6 parts, white sugar 2 ~ 4 parts.
3. instant particles as Chinese medicine as claimed in claim 1, it is in the acute application rescued in the heart and treatment coronary heart diseases and angina pectoris.
4. instant particles as Chinese medicine as claimed in claim 1, its dosage form that can be used for developing comprises tablet, capsule, oral solution, decoction, powder, pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510725963.2A CN105193995A (en) | 2015-11-02 | 2015-11-02 | Quick-acting traditional Chinese medicine granules for treating heart diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510725963.2A CN105193995A (en) | 2015-11-02 | 2015-11-02 | Quick-acting traditional Chinese medicine granules for treating heart diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105193995A true CN105193995A (en) | 2015-12-30 |
Family
ID=54942184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510725963.2A Pending CN105193995A (en) | 2015-11-02 | 2015-11-02 | Quick-acting traditional Chinese medicine granules for treating heart diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105193995A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1621068A (en) * | 2003-11-24 | 2005-06-01 | 马基平 | Quick effective heart rescuing pills |
| CN1772196A (en) * | 2005-11-08 | 2006-05-17 | 吴家录 | Heart failure regulating Chinese medicine |
| CN1857463A (en) * | 2006-04-14 | 2006-11-08 | 王晓忠 | Medicine composition for preventing and treating myocardial ischemia disease |
| CN101406666A (en) * | 2008-11-21 | 2009-04-15 | 刘华钢 | Chinese medicine for treating coronary heart disease and angina pectoris, and preparation method and use thereof |
| CN101972446A (en) * | 2010-08-26 | 2011-02-16 | 葛德钜 | Medicament for treating coronary disease and preparation method thereof |
| CN101991648A (en) * | 2010-11-11 | 2011-03-30 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating diabetic coronary heart disease |
-
2015
- 2015-11-02 CN CN201510725963.2A patent/CN105193995A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1621068A (en) * | 2003-11-24 | 2005-06-01 | 马基平 | Quick effective heart rescuing pills |
| CN1772196A (en) * | 2005-11-08 | 2006-05-17 | 吴家录 | Heart failure regulating Chinese medicine |
| CN1857463A (en) * | 2006-04-14 | 2006-11-08 | 王晓忠 | Medicine composition for preventing and treating myocardial ischemia disease |
| CN101406666A (en) * | 2008-11-21 | 2009-04-15 | 刘华钢 | Chinese medicine for treating coronary heart disease and angina pectoris, and preparation method and use thereof |
| CN101972446A (en) * | 2010-08-26 | 2011-02-16 | 葛德钜 | Medicament for treating coronary disease and preparation method thereof |
| CN101991648A (en) * | 2010-11-11 | 2011-03-30 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating diabetic coronary heart disease |
Non-Patent Citations (1)
| Title |
|---|
| 孟爱君: ""玫瑰花的药理作用"", 《社区医学杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103830636A (en) | Pharmaceutical composition for treating bronchitis and asthma | |
| CN101647972B (en) | Traditional Chinese medicine for treating phthisis | |
| CN102512552B (en) | Traditional Chinese medicine composition for treating exogenous fever | |
| CN103610936B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of coronary heart disease | |
| CN102228618B (en) | Chinese medicinal powder for treating ischemic heart disease | |
| CN104225339A (en) | Chinese medicinal preparation for treating chronic pneumonia and preparation method | |
| CN101129569A (en) | Orally taken traditional Chinese medicine medicinal decoction for treating acute sinusitis | |
| CN103893701B (en) | A kind of Chinese medicine composition alleviating patients suffering from postoperative pain and promote wound healing | |
| CN105193995A (en) | Quick-acting traditional Chinese medicine granules for treating heart diseases | |
| CN102552715B (en) | Chinese medicinal composition, medicine containing Chinese medicinal composition and preparation method of medicine | |
| CN102198182A (en) | Medicament for treatment of interstitial pneumonia | |
| CN102309561B (en) | Pharmaceutical composition used for preventing and treating urarthritis and hyperuricemia | |
| CN103638275B (en) | Chinese medicinal formulae of a kind of coronary flow that increases sharply and preparation method thereof | |
| CN101961474B (en) | Chinese medicinal preparation for treating gastrointestinal diseases | |
| CN101396495B (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease | |
| CN102293891A (en) | Chinese medicine for treating cardiovascular disease and preparation method thereof | |
| CN101244209B (en) | Medicament for preventing or treating cardiovascular and cerebrovascular diseases | |
| CN106074784A (en) | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia | |
| CN105944042A (en) | Traditional Chinese medicine for preventing coronary heart disease | |
| CN105055846A (en) | Sick sinus syndrome and drug for treating same | |
| CN105497190A (en) | Traditional Chinese medicine fumigation pill and production technology thereof | |
| CN102973787B (en) | Traditional Chinese medicine used for treating diabetic cardiac autonomic neuropathy | |
| CN104367896A (en) | Pharmaceutical composition for treating qi deficiency and blood stasis-type apoplexy and preparation method thereof | |
| CN105168653A (en) | Traditional Chinese medicine composition used for treating coronary heart disease | |
| CN102397521B (en) | Tradtional Chinese medicine plaster for preventing and treating stenocardia and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151230 |
|
| RJ01 | Rejection of invention patent application after publication |